利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

11 条记录 (耗时 0.022 秒)

    HOLOGRAM LAMINATE AND METHOD OF MANUFACTURING HOLOGRAM LAMINATE
    1.
    发明申请
    HOLOGRAM LAMINATE AND METHOD OF MANUFACTURING HOLOGRAM LAMINATE 审中-公开
    HOLOGRAM层压板和制造HOLOGRAM LAMINATE的方法

    公开(公告)号：US20120127546A1

    公开(公告)日：2012-05-24

    申请号：US13292750

    申请日：2011-11-09

    申请人： Yoshihiro Sugiura ,  Akira Shirakura

    发明人： Yoshihiro Sugiura ,  Akira Shirakura

    IPC分类号： G03H1/00 ,  B32B37/12 ,  B32B37/14 ,  B32B37/02

    CPC分类号： G03H1/0011 ,  B42D25/328 ,  G03H1/02 ,  G03H1/0252 ,  G03H2240/50 ,  G03H2250/10 ,  G03H2250/12

    摘要： A hologram laminate is provided with a hologram recording layer in which holograms are recorded, a first bonding layer, a pattern layer having a first region and a second region, and a second bonding layer. The hologram recording layer, the first bonding layer, the pattern layer, and the second bonding layer are laminated in this order. Detaching strength of the first bonding layer is larger than detaching strength of the second bonding layer. The detaching strength of the second bonding layer with respect to the first region and the detaching strength of the second bonding layer with respect to the second region are different.

    摘要翻译： 全息图层压板设置有记录有全息图的全息图记录层，第一粘合层，具有第一区域和第二区域的图案层和第二粘合层。 全息记录层，第一粘合层，图案层和第二粘合层按顺序层压。 第一接合层的剥离强度大于第二接合层的剥离强度。 第二接合层相对于第一区域的分离强度和第二接合层相对于第二区域的分离强度是不同的。

    Inhibitor of vascular permeability enhancer
    3.
    发明授权
    Inhibitor of vascular permeability enhancer 失效
    血管通透性增强剂的抑制剂

    公开(公告)号：US5604210A

    公开(公告)日：1997-02-18

    申请号：US456723

    申请日：1995-06-01

    申请人： Akinobu Nagaoka ,  Tetsuji Imamoto ,  Tsuneo Asano ,  Yoshihiro Sugiura ,  Giichi Goto

    发明人： Akinobu Nagaoka ,  Tetsuji Imamoto ,  Tsuneo Asano ,  Yoshihiro Sugiura ,  Giichi Goto

    IPC分类号： A61K31/52 ,  A61K31/70

    CPC分类号： A61K31/7076

    摘要： The present invention relates to prevention or treatment a brain edema, an intracranial hemorrhage and a cerebral infarction by administering a pharmaceutically effective amount of a compound or a pharmaceutically acceptable salt thereof, for inhibiting a vascular permeability enhancer, which the compound is of the formula: ##STR1## wherein A is halogen, --X--R.sup.3 in which X is O, S, NH or NHNH, and R.sup.3 is H, acyl, a hydrocarbon group or an aromatic heterocyclic group, or --Y.dbd.R.sup.4 in which Y is N or NHN, and R.sup.4 is a divalent hydrocarbon group, and R.sup.1 is H, halogen, a hydrocarbon group, a heterocyclic group or --Z--R.sup.5 in which Z is O, S or NH, and R.sup.5 is H, a hydrocarbon group or an aromatic heterocyclic group;R.sup.2 is H, halogen, a hydrocarbon group or a heterocyclic group;B is --W--R.sup.6 in which W is CH.sub.2, CO or CS, and R.sup.6 is OH, alkoxy, acyloxy, alkylsulfinyl, alkylsulfonyl, phosphoric acid or amino, or B together with E form a cyclic phosphoric ester; andD and E are H, amino, azido, halogen or OH.

    摘要翻译： 本发明涉及通过施用药学有效量的化合物或其药学上可接受的盐来抑制血管通透性增强剂来预防或治疗脑水肿，颅内出血和脑梗死，该化合物具有下式： （I）其中A是卤素，X-R 3，其中X是O，S，NH或NHNH，R 3是H，酰基，烃基或芳族杂环基，或-Y = R 4，其中 Y是N或NHN，R4是二价烃基，R1是H，卤素，烃基，杂环基或-Z-R5，其中Z是O，S或NH，R5是H，烃 基团或芳族杂环基团; R2是H，卤素，烃基或杂环基; B为-W-R 6，其中W为CH 2，CO或CS，R 6为OH，烷氧基，酰氧基，烷基亚磺酰基，烷基磺酰基，磷酸或氨基，或B与E一起形成环状磷酸酯; 并且D和E是H，氨基，叠氮基，卤素或OH。

    Aromatic hydroxamix acid compounds, their production and use
    9.
    发明授权
    Aromatic hydroxamix acid compounds, their production and use 失效
    芳香族异羟肟酸化合物，其生产和使用

    公开(公告)号：US5891916A

    公开(公告)日：1999-04-06

    申请号：US662240

    申请日：1996-06-14

    申请人： Kaneyoshi Kato ,  Yoshihiro Sugiura ,  Ken-ichi Naruo ,  Hideki Takahashi

    发明人： Kaneyoshi Kato ,  Yoshihiro Sugiura ,  Ken-ichi Naruo ,  Hideki Takahashi

    IPC分类号： C07C259/06 ,  C07C271/60 ,  C07D277/30 ,  C07C239/08 ,  A61K31/19 ,  C07D277/00

    CPC分类号： C07C271/60 ,  C07C259/06

    摘要： A compound represented by the formula: ##STR1## wherein Ar.sup.1 and Ar.sup.2 independently represent an optionally substituted aromatic group; Q represents an optionally substituted divalent aliphatic hydrocarbon group optionally containing O or S; R.sup.1 represents H, acyl group, etc.; and X represents an electron-withdrawing group, an optionally substituted aromatic group, a group of the formula: ##STR2## wherein R.sup.2 and R.sup.3 independently represent H, acyl group or an optionally substituted hydrocarbon group, etc., etc.; or salts thereof are useful as an excellent anti-neurodegenerative agent.

    摘要翻译： 由下式表示的化合物：其中Ar 1和Ar 2独立地表示任选取代的芳基; Q表示任选含有O或S的任选取代的二价脂族烃基; R1代表H，酰基等; X表示吸电子基团，可以具有取代基的芳基，下式的基团：其中R2和R3独立地表示H，酰基或任意取代的烃基等; 或其盐可用作优异的抗神经变性剂。